In AIS with inadequate response to tenecteplase, tirofiban vs. placebo increased excellent functional outcome rate at 90 d. Alsaaran Z, Hill MD. Ann Intern Med 2026 Sep 1. doi: 10.7326/ANNALS-26-03132.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Alsaaran Z, Hill MD. In AIS with inadequate response to tenecteplase, tirofiban vs. placebo increased excellent functional outcome rate at 90 d. Ann Intern Med 2026 Sep 1. doi: 10.7326/ANNALS-26-03132.
PMID: 42673593